Autonomous Blood Drawing Technology | Medical Robot | Vitestro

Introducing the new standard in blood drawing

Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given the mounting shortages of healthcare personnel, there is a clear need for a future-proof system to guarantee continuity of care.

The Product

Vitestro's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection . The procedure is performed fully automatically, from tourniquet to bandage application.

REQUEST MORE INFORMATION

Featured on

Redefining patient experience

The cornerstone of our approach is an empathic, intuitive and efficient patient experience. The device can be used under supervision by patients of 16 years and older, including those with comorbidities and/or difficult venous access.

Clinical development with R&D partners

Vitestro performs its clinical development activities together with leading European hospitals and laboratories. Automated blood drawing studies have been conducted with healthy volunteers and patients of all ages since 2020.

'More than 1000 patients participated in clinical trials, multiple hospitals participated '
- Toon Overbeeke, CEO Vitestro
'By introducing automated blood drawing, high quality, as well as capacity, is guaranteed in our laboratories.’
- Anja Leyte, Director OLVG Laboratories
'Vitestro's technology helps improving sample standardization and solving staffing shortages at our blood drawing department. Patients are also very positive.'
- Anja Leyte, Director OVLG Laboratories
'Automated blood drawing will play a key role in the future of laboratory medicine.
I can't wait to see the first devices working in our labs.'
- François Verheijen, Clinical Chemist, Result Laboratorium, NL
'It is great to see, during clinical testing, how the device can make a difference for patients.'
- Luuk Giesen, Medical Officer Vitestro

Increasing access to diagnostics

The introduction of Vitestro’s autonomous blood drawing devices increases access to laboratory diagnostics for patients. Continuous operation boosts the availability of blood drawing services, empowering patients to go for a blood draw on their own schedule.

Collaborating with leading hospitals

Vitestro is thrilled to receive extensive support from leading hospitals and clinical laboratories across Europe. Together we will realize a future where our autonomous device has become the standard, transforming patient care for millions of people.

Patient First

The company goals is to provide a high level of patient safety and to reduce anxiety in the blood drawing experience. By standardizing the vast part of the procedure, the device reduces dependency on personnel and increases standardization and quality of the blood drawing procedure.

Autonomous Blood Drawing Technology - Vitestro

Autonomous Blood Drawing Technology | Medical Robot

NEWS

+

-

Vitestro shows its device at WorldLab in Rome with its first international booth

Vitestro garnered a lot of interest by showing the autonomous blood drawing device, at its first international booth. With an accompanying patient journey video, visitors were able to experience what the future of blood drawing holds.

Amsterdam-based OLVG Lab adopts Vitestro’s autonomous blood drawing devices

Amsterdam-based OLVG Lab, a leading Dutch clinical laboratory, will be the first European healthcare provider to introduce multiple autonomous blood drawing devices manufactured by Utrecht-based developer Vitestro. Both parties have signed an agreement for the acquisition of the devices, which will be installed once CE marking has been obtained. The innovation will contribute to safe, consistent blood drawing, as well as helping to solve the growing healthcare workforce shortage.

OLVG Lab kiest voor bloedafname- apparaten van Vitestro

OLVG Lab gaat als eerste Europese instelling meerdere autonome bloedafnameapparaten van de Utrechtse ontwikkelaar Vitestro in gebruik nemen. Beide partijen hebben daartoe een contract ondertekend. De apparaten zullen worden geplaatst na het behalen van de CE-markering en dragen bij aan een veilige, consistente bloedafname, maar ook aan het oplossen van het toenemende tekort aan personeel in de zorg.

Vitestro receives European Innovation Council Accelerator Grant

Vitestro has been selected for a European Innovation Council (EIC) grant. The EIC grant is a competitive grant and the Vitestro team is grateful to receive it.

Vitestro raises EUR 12 million in Series A financing round to bring the world's first autonomous blood drawing device to the European market

Vitestro, developer of an autonomous blood drawing device, announces the completion of a Series A financing round. California-based Sonder Capital led the funding round alongside existing investors.

Vitestro haalt 12 miljoen euro op richting marktintroductie van 's werelds eerste autonome bloedafnameapparaat

Vitestro, ontwikkelaar van een autonoom bloedafnameapparaat, heeft een Serie A-financieringsronde afgerond. Het in Californië gevestigde Sonder Capital leidde de ronde.

Vitestro unveils autonomous blood drawing device, combining artificial intelligence, ultrasound imaging and robotics

Intuitive to use device, empowering patients to be self-efficacious in the full blood collection procedure

Vitestro receives grant from React-EU

Vitestro is proud to have received a grant from REACT-EU, provided by the European Regional Development Fund (EFRD). The REACT-EU programme (Recovery Assistance for Cohesion and the Territories of Europe).

Vitestro onthult geautomatiseerd bloedafnameapparaat dat kunstmatige intelligentie, echografie en robotica combineert

Eenvoudig te bedienen apparaat waarmee patiënten hun bloedafname volledig zelfstandig kunnen uitvoeren

Wessel van Dijk has joined Vitestro

Bringing expertise, experience and passion for customers and patient care from 30 years of successfully growing MedTech organizations.

Journalists and other media professionals

Do you have any questions,
would you like an interview or
additional information?

Please contact.
Brian Joseph
Commercial Director,
+31 30 231 1005,
publicrelations@vitestro.com

REQUEST PRESS KIT

VIEW ALL

ABOUT

+

-

Founding Story

The idea for Vitestro was conceived when Toon and Brian, entrepreneurs and business partners for many years, were discussing frustrations about the availability of care for their loved ones. In Toon's case, a friend's father was very difficult to puncture due to chemotherapy, while Brian's experienced long waiting times and logistic errors when one of his kids needed regular blood checkups.

These personal experiences led to discussions about the cornerstone of good patient care: blood analysis. Together the founders saw an opportunity to improve patient care with autonomous phlebotomy. They decided to start on an adventure together…

Teaming with experts

A few years later, Vitestro’s multi-disciplinary team, with the help of laboratories, hospitals and many other partners is well on their way to transforming patient care globally with the introduction of this innovation. 35+ colleagues joined Vitestro’s mission in the past 5 years. Do you also thrive on great challenges? Check out our careers page.

WORK AT VITESTRO